Drug Database
Back to search

United States· US:50228-184_bcb83203-049e-1ddd-e053-2a95a90ae336

Hydralazine Hydrochloride

A hydralazine product containing hydralazine hydrochloride, registered in United States by ScieGen Pharmaceuticals, Inc.. The same ATC class is registered in 6 of our 19 countries.

ATC C02DB02US label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedHydralazine HydrochlorideATCC02DB02REGISTER NO.US:50228-184_bcb83203…PACKS LISTED4CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about hydralazine hydrochlorideAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Hydralazine is registered in 6 of 19 countries.

Countries holding a registration under ATC C02DB02 (hydralazine), each read from that country’s own register.

  • This record: United States, from FDA National Drug Code directory (United States)
  • 3 of them publish a price we can compare per daily dose
Search hydralazine products by name

Hydralazine · ATC C02DB02

6 / 19 countries

  • Canada
  • Finlandprice
  • Japan
  • Norwayprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
HYDRALAZINE HYDROCHLORIDE
Manufacturer
ScieGen Pharmaceuticals, Inc.
Country
United States (US)
ATC code
C02DB02
ATC class
Hydralazine
Defined daily dose
0.1 g, O
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 4

  • ndc11
    5022818401
    100 TABLET in 1 BOTTLE (50228-184-01)
  • ndc11
    5022818410
    1000 TABLET in 1 BOTTLE (50228-184-10)
  • ndc11
    50228-184-01
  • ndc11
    50228-184-10

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

163 interactions on record for hydralazine.

Graded by severity as the source publishes them — 145 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check hydralazine against other medicinesHow interaction checks work

Hydralazine · interactions on record

163 records

  • 145 moderate
  • 1 minor
  • 17 info

Most severe, free to view

  • ThiethylperazinA04AB03moderate
  • DiphenhydraminA04AB05moderate
  • DronabinolA04AD10moderate
  • NabiloneA04AD11moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Hydralazine in 5 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All hydralazine products

Authorised across Europe · EMA

The same active substance is authorised in 6 EEA countries. Names it is sold under:

  • Cyprus · Hydralazine Remedica
  • Spain · Hydrapres
  • United Kingdom (Northern Ireland) · Apresoline, Hydralazine Accord-Uk
  • Malta · Hydralazine Remedica
  • Norway · Apresolin
  • Sweden · Apresolin

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/cb0e8bbc-e5fa-4b83-9b44-0bc0aa313222
GET /v1/drugs/cb0e8bbc-e5fa-4b83-9b44-0bc0aa313222?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "ORAL",
  "source": "ndc",
  "strength": "50",
  "substance": "HYDRALAZINE HYDROCHLORIDE",
  "productndc": "50228-184",
  "dosage_form": "TABLET",
  "dea_schedule": null,
  "strength_unit": "mg/1",
  "application_number": "ANDA205236",
  "marketing_category": "ANDA"
}
API referenceMCP serverPlans

See everything about hydralazine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console